Blog

Welcome to CrownBio’s Blog where we share our thoughts
on the latest trends and hot stories in Oncology and CVMD

blog.png
August 23, 2016 Put Your Glasses On, Tumor Pharmacology Goes 3D Attrition rates in oncology drug development are higher than in other disease areas, with almost 95% of compounds showing preclinical activity failing to reach clinical development. This indicates a disconnect between current preclinical models and tumors in patients. CrownBio, in collaboration with the University of Nottingham, has recently developed a ... LEARN MORE
August 2, 2016 Study Finds Perfect Therapeutic Match To Fight a Common Form of Leukemia Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer, characterized by an excessive ... LEARN MORE